Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC11082 | Danicopan (ACH-4471) Featured |
Danicopan (ACH-4471, ACH-0144471) is a highly potent, orally active Factor D inhibitor with Kd of 0.54 nM, inhibits the proteolytic activity of purified Factor D against substrate Factor B in complex with C3b, blocking production of Bb fragment IC50 of 15 nM.
More description
|
![]() |
DC11920 | Arimoclomol maleate Featured |
A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response.
More description
|
![]() |
DCAPI1091 | Conivaptan hydrochloride Featured |
Conivaptan(YM 087) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist) with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.
More description
|
![]() |
DCAPI1485 | Silodosin Featured |
Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. Silodosin causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it ca
More description
|
![]() |
DC11688 | Avacopan Featured |
Avacopan is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM.
More description
|
![]() |
DC11044 | Omidenepag Isopropyl Featured |
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma.
More description
|
![]() |
DC8895 | benzbromaron Featured |
Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout.
More description
|
![]() |
DC11512 | Acrizanib Featured |
Acrizanib(LHA510) is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
More description
|
![]() |
DC4160 | CB-03-01 Featured |
CB-03-01 is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use.
More description
|
![]() |
DC8198 | RTA-408(Omaveloxolone) Featured |
RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-κB.
More description
|
![]() |
DC11394 | Fulacimstat(BAY 1142524) Featured |
Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor.
More description
|
![]() |
DC9148 | Tolvaptan Featured |
Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.
More description
|
![]() |
DC10853 | LAU159 Featured |
LAU159 is a novelα6β3γ2 GABAA receptor inhibitor.
More description
|
![]() |
DC9938 | Lusutrombopag(S-888711) Featured |
Lusutrombopag(S-888711) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.
More description
|
![]() |
DC9527 | Methylnaltrexone (Bromide) Featured |
Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.
More description
|
![]() |
DC9187 | Mosapride Citrate |
Mosapride citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
More description
|
![]() |
DC8185 | Verosudil(AR-12286) |
Rho-kinase (ROCK) inhibitor
More description
|
![]() |
DCAPI1305 | Pramiracetam |
Pramiracetam
More description
|
![]() |
DC10299 | Olumacostat glasaretil |
Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC).
More description
|
|
DCAPI1342 | Nepafenac |
Nepafenac
More description
|
![]() |
DC10326 | Mozavaptan |
Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM.
More description
|
|
DC7172 | IOWH-032 |
iOWH032 is a novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays.
More description
|
![]() |
DC11187 | Fonadelpar |
Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders..
More description
|
![]() |
DC11433 | Vatiquinone |
EPI-743 (Vatiquinone,EPI-589) is an orally bioavailable para-benzoquinone for treatment of inherited mitochondrial diseases, an analogue of the antioxidant ubidecarenone.
More description
|
![]() |
DC10314 | Emixustat |
Emixustat, a novel visual cycle modulator, is an inhibitor of the visual cycle isomerase with an IC50 value of 4.4 nM in vitro.
More description
|
![]() |
DC10939 | Edasalonexent |
Edasalonexent (CAT-1004) is a bifunctional, orally administered small molecule that covalently links 2 compounds known to inhibit NF‐κB, salicylic acid and docosahexaenoic acid (DHA).
More description
|
![]() |
DC9116 | Dantrolene sodium |
Dantrolene sodium is a inhibitor of calcium channel proteins, inhibiting the release of Ca2+ from the sarcoplasm. Dantrolene sodium is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction.
More description
|
![]() |
DC9183 | Clomiphene citrate |
Clomifene Citrate is a selective estrogen receptor modulator.
More description
|
![]() |
DC11354 | Carteolol (hydrochloride) |
Carteolol is an antagonist of β-adrenergic receptors (Kd = 13 nM).
More description
|
![]() |
DC8971 | Baclofen |
Baclofen is a gamma-amino-butyric acid (GABA) derivative used as a skeletal muscle relaxant.
More description
|
![]() |